{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:26Z","timestamp":1793307986068,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Celiac disease (CeD) is an autoimmune enteropathy triggered by gluten in genetically predisposed individuals, causing intestinal damage and impaired gut barrier integrity. Current diagnostic methods, such as serology and intestinal biopsy, are costly and invasive. Intestinal fatty acid binding protein (FABP2), exclusively expressed in the cytosol of mature enterocytes and released during injury, offers a potential non-invasive alternative biomarker. This study aimed to evaluate urinary FABP2 levels in pediatric patients undergoing gastrointestinal assessment or CeD follow-up to determine its potential as a non-invasive biomarker of intestinal integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective cross-sectional study, urinary FABP2 was measured in 103 pediatric patients evaluated for intestinal permeability using the lactulose\/mannitol test. Based on serology and symptomatology, patients were categorized as controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200965), CeD on gluten-free diet (GFD)\u2009&amp;gt;\u20096 months (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926), or active CeD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912). Associations between FABP2 levels, serology, symptoms, and diagnosis were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FABP2 levels were significantly elevated in active CeD patients (47.7\u2005pg\/mL) compared with controls (9.65\u2005pg\/mL) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05), but not in CeD patients on GFD (15.0\u2005pg\/mL). A receiver operating characteristic curve analysis confirmed the diagnostic potential of FABP2 as a biomarker for celiac disease (area under the curve\u2009=\u20090.7269; cutoff\u2009=\u200923.7\u2005pg\/mL; sensitivity\u2009=\u200966.7%, specificity\u2009=\u200976.9%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate that urinary FABP2 reflects intestinal epithelial injury and may serve as a non-invasive biomarker for assessing gut integrity and disease activity in CeD. However, larger prospective studies with histological correlation are needed to validate its diagnostic utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1838294","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:28:04Z","timestamp":1781065684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary fatty acid binding protein 2 as a biomarker of intestinal injury in pediatric celiac disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Vijay","family":"Mehta","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology, Orlando Health Arnold Palmer Hospital for Children","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Specialty Diagnostic Clinical and Translational Research Lab, Orlando Health Arnold Palmer Hospital for Children","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Milliron","sequence":"additional","affiliation":[{"name":"University of Central Florida","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Stoeckel","sequence":"additional","affiliation":[{"name":"Specialty Diagnostic Clinical and Translational Research Lab, Orlando Health Arnold Palmer Hospital for Children","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Ballelos","sequence":"additional","affiliation":[{"name":"University of Central Florida","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Tiqui","sequence":"additional","affiliation":[{"name":"University of Central Florida","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirajyoti","family":"Deb","sequence":"additional","affiliation":[{"name":"University of Central Florida","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Abomoelak","sequence":"additional","affiliation":[{"name":"Specialty Diagnostic Clinical and Translational Research Lab, Orlando Health Arnold Palmer Hospital for Children","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Schreck","sequence":"additional","affiliation":[{"name":"Orlando Health Medical Group Pediatric Specialty Practice Resources","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"Mehta","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Orlando Health Arnold Palmer Hospital for Children","place":["Orlando, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cgh.2023.09.042","article-title":"Gluten-related disorders from bench to bedside","volume":"22","author":"Jansson-Knodell","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41575-021-00511-8","article-title":"Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease","volume":"18","author":"Pinto-Sanchez","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cells8020193","article-title":"Cellular and molecular therapeutic targets in inflammatory bowel disease-focusing on intestinal barrier function","volume":"8","author":"Schoultz","year":"2019","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-025-03854-0","article-title":"Investigating intestinal epithelium metabolic dysfunction in celiac disease using personalized genome-scale models","volume":"23","author":"McCreery","year":"2025","journal-title":"BMC Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/0891693021000008526","article-title":"Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele","volume":"35","author":"Kuitunen","year":"2002","journal-title":"Autoimmunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10620-005-2574-0","article-title":"Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet","volume":"50","author":"Duerksen","year":"2005","journal-title":"Dig Dis Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/nu13072274","article-title":"Challenges of monitoring the gluten-free diet adherence in the management and follow-up of patients with celiac disease","volume":"13","author":"Wieser","year":"2021","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2036.2009.04110.x","article-title":"Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease","volume":"31","author":"Lewis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s10238-023-01040-1","article-title":"Study of the immune response in celiac patients with selective IgA deficiency who start a gluten-free diet","volume":"23","author":"Giner-P\u00e9rez","year":"2023","journal-title":"Clin Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0009-9120(03)00096-1","article-title":"Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility","volume":"36","author":"Pelsers","year":"2003","journal-title":". Clin Biochem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00418-009-0608-y","article-title":"Localization, function and regulation of the two intestinal fatty acid-binding protein types","volume":"132","author":"Levy","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1038\/s41598-017-07242-4","article-title":"Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP","volume":"7","author":"Adriaanse","year":"2017","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/apm.12800","article-title":"Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease","volume":"126","author":"Oldenburger","year":"2018","journal-title":"Apmis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e070","DOI":"10.1097\/PG9.0000000000000070","article-title":"Intestinal fatty acid binding protein levels in pediatric celiac patients in transition from active disease to clinical and serological remission","volume":"2","author":"Hoofien","year":"2021","journal-title":"JPGN Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jgh.14852","article-title":"Non-immunological biomarkers for assessment of villous abnormalities in patients with celiac disease","volume":"35","author":"Singh","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12876-022-02334-6","article-title":"Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn\u2019s disease","volume":"22","author":"Logan","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"5727312","DOI":"10.1155\/2016\/5727312","article-title":"Urinary intestinal fatty acid-binding protein can distinguish necrotizing enterocolitis from sepsis in early stage of the disease","volume":"2016","author":"Coufal","year":"2016","journal-title":"J Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/children8100842","article-title":"The physiologic significance of early urinary intestinal fatty acid binding protein levels in preterm infants: a prospective cohort study","volume":"8","author":"Jung","year":"2021","journal-title":"Children"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s10620-007-0184-8","article-title":"Lactulose\/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn\u2019s disease","volume":"53","author":"Dastych","year":"2008","journal-title":"Dig Dis Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.5056\/jnm.2012.18.4.443","article-title":"Techniques of functional and motility test: how to perform and interpret intestinal permeability","volume":"18","author":"Mishra","year":"2012","journal-title":"J Neurogastroenterol Motil"},{"key":"B24","volume-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"B25","volume-title":"Table1: Tables of Descriptive Statistics in HTML","author":"Rich","year":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"16060","DOI":"10.1016\/S0021-9258(18)47696-X","article-title":"The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships","volume":"262","author":"Sweetser","year":"1987","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/jama.2016.10395","article-title":"Screening for celiac disease: evidence report and systematic review for the US preventive services task force","volume":"317","author":"Chou","year":"2017","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MPG.0000000000001270","article-title":"Normalization time of celiac serology in children on a gluten-free diet","volume":"64","author":"Gidrewicz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2017.05.015","article-title":"Tests for Serum transglutaminase and endomysial antibodies do not detect most patients with celiac disease and persistent villous atrophy on gluten-free diets: a meta-analysis","volume":"153","author":"Silvester","year":"2017","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12664-025-01796-2","article-title":"Role of intestinal fatty acid binding protein in the non-invasive diagnosis of celiac disease in children","volume":"45","author":"Kaul","year":"2025","journal-title":"Indian J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MCG.0b013e31819194b0","article-title":"A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP","volume":"43","author":"Derikx","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ajg.2016.162","article-title":"Serum I-FABP detects gluten responsiveness in adult celiac disease patients on a short-term gluten challenge","volume":"111","author":"Adriaanse","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3109\/00365529209000144","article-title":"Antigliadin antibody, D-xylose, and cellobiose\/mannitol permeability tests as indicators of mucosal damage in children with coeliac disease","volume":"27","author":"Troncone","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00005176-199507000-00012","article-title":"Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease","volume":"21","author":"Troncone","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005176-198910000-00004","article-title":"Intestinal permeability to inert sugars and different-sized polyethyleneglycols in children with celiac disease","volume":"9","author":"Stenhammar","year":"1989","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","article-title":"Additional value of serum I-FABP levels for evaluating celiac disease activity in children","volume":"46","author":"Vreugdenhil","year":"2011","journal-title":"Scand J Gastroenterol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1838294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:28:08Z","timestamp":1781065688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1838294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":37,"alternative-id":["10.3389\/fped.2026.1838294"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1838294","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1838294"}}